$PRLB Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Proto Labs Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Proto Labs Inc. Get notifications about new insider transactions in Proto Labs Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 20 2021 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 1,520 | 0 | 25,779 | 24.3 K to 25.8 K (+6.27 %) |
May 20 2021 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,520 | 0 | 14,106 | 12.6 K to 14.1 K (+12.08 %) |
May 20 2021 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Director | Grant | A | 0.00 | 1,520 | 0 | 8,264 | 6.7 K to 8.3 K (+22.54 %) |
May 06 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 102.75 | 375 | 38,531 | 20,613 | 21 K to 20.6 K (-1.79 %) |
Mar 03 2021 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 151.19 | 1,000 | 151,185 | 12,586 | 13.6 K to 12.6 K (-7.36 %) |
Mar 03 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 150.86 | 9,652 | 1,456,101 | 9,652 | |
Mar 03 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 0.00 | 4,309 | 0 | 21,556 | 17.2 K to 21.6 K (+24.98 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | A | 180.46 | 3,442 | 621,143 | 3,442 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | M | 58.35 | 3,628 | 211,694 | 907 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | M | 60.96 | 3,474 | 211,775 | 1,737 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | A | 180.46 | 3,442 | 621,143 | 3,442 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Grant | A | 0.00 | 4,212 | 0 | 20,988 | 16.8 K to 21 K (+25.11 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | M | 58.35 | 3,628 | 211,694 | 907 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 197.05 | 1,087 | 214,193 | 16,776 | 17.9 K to 16.8 K (-6.09 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Option Exercise | M | 60.96 | 3,474 | 211,775 | 1,737 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 196.26 | 2,000 | 392,520 | 17,863 | 19.9 K to 17.9 K (-10.07 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Grant | A | 0.00 | 4,212 | 0 | 20,988 | 16.8 K to 21 K (+25.11 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 186.82 | 700 | 130,775 | 19,863 | 20.6 K to 19.9 K (-3.40 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 197.05 | 1,087 | 214,193 | 16,776 | 17.9 K to 16.8 K (-6.09 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 185.66 | 2,100 | 389,887 | 20,563 | 22.7 K to 20.6 K (-9.27 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 196.26 | 2,000 | 392,520 | 17,863 | 19.9 K to 17.9 K (-10.07 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 184.85 | 1,500 | 277,275 | 22,663 | 24.2 K to 22.7 K (-6.21 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 186.82 | 700 | 130,775 | 19,863 | 20.6 K to 19.9 K (-3.40 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 183.69 | 900 | 165,318 | 24,163 | 25.1 K to 24.2 K (-3.59 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 185.66 | 2,100 | 389,887 | 20,563 | 22.7 K to 20.6 K (-9.27 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 182.81 | 1,100 | 201,093 | 25,063 | 26.2 K to 25.1 K (-4.20 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 184.85 | 1,500 | 277,275 | 22,663 | 24.2 K to 22.7 K (-6.21 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 181.09 | 802 | 145,235 | 26,163 | 27 K to 26.2 K (-2.97 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 183.69 | 900 | 165,318 | 24,163 | 25.1 K to 24.2 K (-3.59 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Buy | M | 58.35 | 3,628 | 211,694 | 26,965 | 23.3 K to 27 K (+15.55 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 182.81 | 1,100 | 201,093 | 25,063 | 26.2 K to 25.1 K (-4.20 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Buy | M | 60.96 | 3,474 | 211,775 | 23,337 | 19.9 K to 23.3 K (+17.49 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 181.09 | 802 | 145,235 | 26,163 | 27 K to 26.2 K (-2.97 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Buy | M | 58.35 | 3,628 | 211,694 | 26,965 | 23.3 K to 27 K (+15.55 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Buy | M | 60.96 | 3,474 | 211,775 | 23,337 | 19.9 K to 23.3 K (+17.49 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | M | 57.88 | 18,910 | 1,094,511 | 0 | |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Payment of Exercise | F | 197.05 | 3,619 | 713,124 | 54,840 | 58.5 K to 54.8 K (-6.19 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 189.28 | 1,258 | 238,120 | 58,459 | 59.7 K to 58.5 K (-2.11 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | M | 57.88 | 18,910 | 1,094,511 | 0 | |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 188.53 | 9,540 | 1,798,608 | 59,717 | 69.3 K to 59.7 K (-13.77 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Payment of Exercise | F | 197.05 | 3,619 | 713,124 | 54,840 | 58.5 K to 54.8 K (-6.19 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 187.66 | 8,112 | 1,522,314 | 69,257 | 77.4 K to 69.3 K (-10.48 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 189.28 | 1,258 | 238,120 | 58,459 | 59.7 K to 58.5 K (-2.11 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Buy | M | 57.88 | 18,910 | 1,094,511 | 77,369 | 58.5 K to 77.4 K (+32.35 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 188.53 | 9,540 | 1,798,608 | 59,717 | 69.3 K to 59.7 K (-13.77 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 187.66 | 8,112 | 1,522,314 | 69,257 | 77.4 K to 69.3 K (-10.48 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Buy | M | 57.88 | 18,910 | 1,094,511 | 77,369 | 58.5 K to 77.4 K (+32.35 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 180.46 | 2,190 | 395,207 | 2,190 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 0.00 | 3,104 | 0 | 17,247 | 14.1 K to 17.2 K (+21.95 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Payment of Exercise | F | 197.05 | 1,337 | 263,456 | 14,143 | 15.5 K to 14.1 K (-8.64 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 180.46 | 2,190 | 395,207 | 2,190 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 0.00 | 3,104 | 0 | 17,247 | 14.1 K to 17.2 K (+21.95 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Payment of Exercise | F | 197.05 | 1,337 | 263,456 | 14,143 | 15.5 K to 14.1 K (-8.64 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Option Exercise | A | 180.46 | 1,826 | 329,520 | 1,826 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Grant | A | 0.00 | 2,365 | 0 | 9,484 | 7.1 K to 9.5 K (+33.22 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 197.05 | 455 | 89,658 | 7,119 | 7.6 K to 7.1 K (-6.01 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Option Exercise | A | 180.46 | 1,826 | 329,520 | 1,826 | |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Grant | A | 0.00 | 2,365 | 0 | 9,484 | 7.1 K to 9.5 K (+33.22 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 197.05 | 455 | 89,658 | 7,119 | 7.6 K to 7.1 K (-6.01 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 180.46 | 3,128 | 564,479 | 3,128 | |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,433 | 0 | 33,657 | 29.2 K to 33.7 K (+15.17 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 197.05 | 2,171 | 427,796 | 29,224 | 31.4 K to 29.2 K (-6.92 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 180.46 | 3,128 | 564,479 | 3,128 | |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,433 | 0 | 33,657 | 29.2 K to 33.7 K (+15.17 %) |
Feb 18 2021 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 197.05 | 2,171 | 427,796 | 29,224 | 31.4 K to 29.2 K (-6.92 %) |
Dec 22 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 53.34 | 2,000 | 106,680 | 715 | |
Dec 22 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Sell | S | 160.00 | 2,000 | 320,008 | 24,259 | 26.3 K to 24.3 K (-7.62 %) |
Dec 22 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 53.34 | 2,000 | 106,680 | 26,259 | 24.3 K to 26.3 K (+8.24 %) |
Dec 03 2020 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 136.34 | 489 | 66,670 | 7,574 | 8.1 K to 7.6 K (-6.06 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | M | 67.15 | 17,990 | 1,208,029 | 0 | |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 161.14 | 800 | 128,912 | 58,459 | 59.3 K to 58.5 K (-1.35 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 159.19 | 400 | 63,676 | 59,259 | 59.7 K to 59.3 K (-0.67 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 157.81 | 1,200 | 189,368 | 59,659 | 60.9 K to 59.7 K (-1.97 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 156.60 | 2,330 | 364,882 | 60,859 | 63.2 K to 60.9 K (-3.69 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 155.50 | 3,158 | 491,061 | 63,189 | 66.3 K to 63.2 K (-4.76 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 154.45 | 3,219 | 497,160 | 66,347 | 69.6 K to 66.3 K (-4.63 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 153.69 | 2,617 | 402,196 | 69,566 | 72.2 K to 69.6 K (-3.63 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Sell | S | 152.43 | 4,266 | 650,272 | 72,183 | 76.4 K to 72.2 K (-5.58 %) |
Sep 08 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Buy | M | 67.15 | 17,990 | 1,208,029 | 76,449 | 58.5 K to 76.4 K (+30.77 %) |
Aug 26 2020 | PRLB | Proto Labs Inc | Goodman John B | Director | Sell | S | 132.75 | 1,000 | 132,746 | 13,586 | 14.6 K to 13.6 K (-6.86 %) |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Option Exercise | M | 30.58 | 762 | 23,302 | 0 | |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Option Exercise | M | 30.58 | 4,000 | 122,320 | 762 | |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Sell | S | 131.00 | 762 | 99,822 | 14,386 | 15.1 K to 14.4 K (-5.03 %) |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Buy | M | 30.58 | 762 | 23,302 | 15,148 | 14.4 K to 15.1 K (+5.30 %) |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Sell | S | 130.05 | 4,000 | 520,213 | 14,386 | 18.4 K to 14.4 K (-21.76 %) |
Aug 12 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Buy | M | 30.58 | 4,000 | 122,320 | 18,386 | 14.4 K to 18.4 K (+27.80 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 62.90 | 2,608 | 164,043 | 0 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 57.88 | 8,348 | 483,182 | 2,837 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 67.15 | 4,995 | 335,414 | 0 | |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 133.66 | 200 | 26,731 | 31,150 | 31.4 K to 31.2 K (-0.64 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 132.53 | 2,050 | 271,683 | 31,350 | 33.4 K to 31.4 K (-6.14 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 131.44 | 13,701 | 1,800,831 | 33,400 | 47.1 K to 33.4 K (-29.09 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 62.90 | 2,608 | 164,043 | 47,101 | 44.5 K to 47.1 K (+5.86 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 57.88 | 8,348 | 483,182 | 44,493 | 36.1 K to 44.5 K (+23.10 %) |
Aug 10 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 67.15 | 4,995 | 335,414 | 36,145 | 31.2 K to 36.1 K (+16.04 %) |
May 21 2020 | PRLB | Proto Labs Inc | Black Archie C. | Director | Grant | A | 0.00 | 1,197 | 0 | 8,309 | 7.1 K to 8.3 K (+16.83 %) |
May 21 2020 | PRLB | Proto Labs Inc | Chand Sujeet | Director | Grant | A | 0.00 | 1,197 | 0 | 6,744 | 5.5 K to 6.7 K (+21.58 %) |
May 21 2020 | PRLB | Proto Labs Inc | Chin Moonhie | Director | Grant | A | 0.00 | 1,197 | 0 | 2,187 | 990 to 2.2 K (+120.91 %) |
May 21 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 1,197 | 0 | 24,259 | 23.1 K to 24.3 K (+5.19 %) |
May 21 2020 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,197 | 0 | 14,586 | 13.4 K to 14.6 K (+8.94 %) |
May 21 2020 | PRLB | Proto Labs Inc | KRANTZ DONALD G | Director | Grant | A | 0.00 | 1,197 | 0 | 6,744 | 5.5 K to 6.7 K (+21.58 %) |
May 21 2020 | PRLB | Proto Labs Inc | WEHRWEIN SVEN | Director | Grant | A | 0.00 | 1,197 | 0 | 14,386 | 13.2 K to 14.4 K (+9.08 %) |
May 20 2020 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Sell | S | 115.07 | 1,988 | 228,751 | 19,863 | 21.9 K to 19.9 K (-9.10 %) |
May 06 2020 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 94.22 | 252 | 23,743 | 21,593 | 21.8 K to 21.6 K (-1.15 %) |
May 04 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Sell | S | 109.00 | 3,773 | 411,257 | 15,223 | 19 K to 15.2 K (-19.86 %) |
May 04 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Sell | S | 107.00 | 3,118 | 333,626 | 18,996 | 22.1 K to 19 K (-14.10 %) |
May 04 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Sell | S | 101.85 | 2,790 | 284,162 | 22,114 | 24.9 K to 22.1 K (-11.20 %) |
Apr 15 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 30.58 | 2,381 | 72,811 | 0 | |
Apr 15 2020 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 30.58 | 2,381 | 72,811 | 23,062 | 20.7 K to 23.1 K (+11.51 %) |
Feb 18 2020 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 100.00 | 838 | 83,800 | 21,845 | 22.7 K to 21.8 K (-3.69 %) |
Feb 18 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Payment of Exercise | F | 100.00 | 1,245 | 124,500 | 24,904 | 26.1 K to 24.9 K (-4.76 %) |
Feb 18 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Payment of Exercise | F | 100.00 | 2,642 | 264,200 | 54,590 | 57.2 K to 54.6 K (-4.62 %) |
Feb 18 2020 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 100.00 | 212 | 21,200 | 8,063 | 8.3 K to 8.1 K (-2.56 %) |
Feb 12 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Option Exercise | A | 96.72 | 10,187 | 985,287 | 10,187 | |
Feb 12 2020 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Grant | A | 0.00 | 8,530 | 0 | 57,232 | 48.7 K to 57.2 K (+17.51 %) |
Feb 12 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | A | 96.72 | 5,501 | 532,057 | 5,501 | |
Feb 12 2020 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Grant | A | 0.00 | 4,607 | 0 | 32,906 | 28.3 K to 32.9 K (+16.28 %) |
Feb 12 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Option Exercise | A | 96.72 | 3,668 | 354,769 | 3,668 | |
Feb 12 2020 | PRLB | Proto Labs Inc | Bodor Robert | VP/General Manager- ... | Grant | A | 0.00 | 3,071 | 0 | 26,149 | 23.1 K to 26.1 K (+13.31 %) |
Dec 03 2019 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 95.83 | 477 | 45,711 | 6,227 | 6.7 K to 6.2 K (-7.12 %) |
Dec 03 2019 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 95.83 | 195 | 18,687 | 28,299 | 28.5 K to 28.3 K (-0.68 %) |
Nov 12 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 30.58 | 2,381 | 72,811 | 2,381 | |
Nov 12 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 30.58 | 2,381 | 72,811 | 20,681 | 18.3 K to 20.7 K (+13.01 %) |
Aug 05 2019 | PRLB | Proto Labs Inc | Chin Moonhie | Director | Grant | A | 0.00 | 990 | 0 | 990 | 0 to 990 |
May 17 2019 | PRLB | Proto Labs Inc | Black Archie C. | Director | Grant | A | 0.00 | 1,311 | 0 | 7,112 | 5.8 K to 7.1 K (+22.60 %) |
May 17 2019 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,311 | 0 | 13,389 | 12.1 K to 13.4 K (+10.85 %) |
May 17 2019 | PRLB | Proto Labs Inc | Black Archie C. | Director | Grant | A | 0.00 | 1,311 | 0 | 7,112 | 5.8 K to 7.1 K (+22.60 %) |
May 17 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 1,311 | 0 | 18,300 | 17 K to 18.3 K (+7.72 %) |
May 17 2019 | PRLB | Proto Labs Inc | Goodman John B | Director | Grant | A | 0.00 | 1,311 | 0 | 13,389 | 12.1 K to 13.4 K (+10.85 %) |
May 17 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Grant | A | 0.00 | 1,311 | 0 | 18,300 | 17 K to 18.3 K (+7.72 %) |
May 17 2019 | PRLB | Proto Labs Inc | Chand Sujeet | Director | Grant | A | 0.00 | 1,311 | 0 | 5,547 | 4.2 K to 5.5 K (+30.95 %) |
May 07 2019 | PRLB | Proto Labs Inc | Baker Arthur R. III | Chief Technology Of ... | Payment of Exercise | F | 110.55 | 252 | 27,859 | 19,123 | 19.4 K to 19.1 K (-1.30 %) |
Feb 15 2019 | PRLB | Proto Labs Inc | HOLT VICTORIA M | President and CEO | Payment of Exercise | F | 108.47 | 2,459 | 266,728 | 48,702 | 51.2 K to 48.7 K (-4.81 %) |
Feb 15 2019 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 108.47 | 1,435 | 155,654 | 28,021 | 29.5 K to 28 K (-4.87 %) |
Feb 15 2019 | PRLB | Proto Labs Inc | FEIN DAVID M | Chief Revenue Offic ... | Payment of Exercise | F | 108.47 | 688 | 74,627 | 12,009 | 12.7 K to 12 K (-5.42 %) |
Feb 13 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 5.56 | 700 | 3,892 | 0 | |
Feb 13 2019 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 5.56 | 700 | 3,892 | 16,989 | 16.3 K to 17 K (+4.30 %) |
Dec 20 2018 | PRLB | Proto Labs Inc | Klaas Bjoern | VP and Mng Director ... | Payment of Exercise | F | 126.93 | 477 | 60,546 | 4,818 | 5.3 K to 4.8 K (-9.01 %) |
Dec 19 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Payment of Exercise | F | 126.93 | 291 | 36,937 | 25,212 | 25.5 K to 25.2 K (-1.14 %) |
Oct 24 2018 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 5.56 | 800 | 4,448 | 700 | |
Oct 24 2018 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Option Exercise | M | 5.56 | 800 | 4,448 | 1,500 | |
Oct 24 2018 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 5.56 | 800 | 4,448 | 16,289 | 15.5 K to 16.3 K (+5.16 %) |
Oct 24 2018 | PRLB | Proto Labs Inc | Gawlick Rainer | Director | Buy | M | 5.56 | 800 | 4,448 | 15,489 | 14.7 K to 15.5 K (+5.45 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 57.88 | 3,000 | 173,640 | 11,185 | |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Option Exercise | M | 67.15 | 5,000 | 335,750 | 4,995 | |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 160.14 | 4,644 | 743,692 | 25,503 | 30.1 K to 25.5 K (-15.40 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Sell | S | 157.66 | 3,356 | 529,105 | 30,147 | 33.5 K to 30.1 K (-10.02 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 57.88 | 3,000 | 173,640 | 33,503 | 30.5 K to 33.5 K (+9.84 %) |
Sep 26 2018 | PRLB | Proto Labs Inc | WAY JOHN | Chief Financial Off ... | Buy | M | 67.15 | 5,000 | 335,750 | 30,503 | 25.5 K to 30.5 K (+19.61 %) |
Sep 18 2018 | PRLB | Proto Labs Inc | Goodman John B | Director | Option Exercise | M | 70.00 | 536 | 37,520 | 0 |